Momenta Pharmaceuticals Inc. (MNTA)

9.60
NASDAQ : Health Technology
Prev Close 10.15
Day Low/High 9.60 / 10.25
52 Wk Low/High 9.55 / 32.20
Avg Volume 457.20K
Exchange NASDAQ
Shares Outstanding 98.61M
Market Cap 1.00B
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Momenta Rated New buy at Stifel

The Stock Market Is on Autopilot

The Stock Market Is on Autopilot

This market is badly in need of some resets as it has been nearly straight up the first week of the year.

Momenta Shares Down On Phase 1 Data for Biosimilar -- Biotech Movers

Momenta Shares Down On Phase 1 Data for Biosimilar -- Biotech Movers

The Cambridge, Mass.-based company and Mylan said that M834, a proposed biosimilar of Orencia (abatacept), did not achieve its primary pharmacokinetic endpoints in a Phase 1 study.

Mylan Soars After FDA Approval for Generic Copaxone --Biotech Movers

Mylan Soars After FDA Approval for Generic Copaxone --Biotech Movers

The pharmaceutical company on Oct. 3 said the FDA has approved its generic version of Teva's multiple sclerosis drug Copaxone.

Momenta downgraded at Leerink

Prepare for Biotech Action Aplenty Today

As we await the jobs report, there is significant news across the biotech sector in the past 24 hours on some names I have mentioned in these pages. Amgen should be up nicely today after a judge stated that Regeneron would have to pull its PCKS9 inh...

Shark Bites: Energous, NeoPhotonics Top My Watch List

Shark Bites: Energous, NeoPhotonics Top My Watch List

The market action is solid today as my hunt for individual stock picks continues.